Robert Safian, MD

The Angiomax Peripheral Procedure Registry of Vascular Events Trial (APPROVE): In-Hospital and 30-Day Results

08/01/2008

David E. Allie , MD;

John J. Young , MD;

John R. Laird , MD, FACC, FACP;

Patrick Hall , MD;

Nicolas W. Shammas , MD, MS, FACC, FSCAI, FACP, FSVM;

Robert Safian , MD;

Ajay Virmani , MD;

Peripheral arterial disease (PAD) affects 8–12 million Americans with an estimated 12–20% of the population > 65 years of age afflicted. Approximately 50% of patients are asymptomatic, which may explain why this disease is often...

Peripheral arterial disease...

08/01/2008

Journal of Invasive Cardiology

Predictors of In-hospital and 30-day Complications of Peripheral Vascular Interventions Using Bivalirudin as the Primary Anticoa

08/01/2008

Patrick Hall , MD;

Robert Safian , MD;

Ajay Virmani , MD;

Nicolas W. Shammas , MD, MS, FACC, FSCAI, FACP, FSVM;

John J. Young , MD;

David E. Allie , MD;

John R. Laird , MD, FACC, FACP;

Predictors of complications in peripheral percutaneous interventions (PPI) with bivalirudin as a base anticoagulant have not yet been defined. The Angiomax Peripheral Procedure Registry of Vascular Events (APPROVE)1 offers a unique...

Predictors of complications in...

08/01/2008

Journal of Invasive Cardiology